Literature DB >> 24660755

Apoptosis signal-regulating kinase 1 as a therapeutic target.

Yosuke Kawarazaki1, Hidenori Ichijo, Isao Naguro.   

Abstract

INTRODUCTION: All organisms are ordinarily exposed to various stresses. It is important for organisms to possess appropriate stress response mechanisms and to maintain homeostasis because the disruption of a stress response system can cause various diseases. Apoptosis signal-regulating kinase 1 (ASK1) is one of the stress-responsive MAP3Ks. ASK1 plays an important role in the response to reactive oxygen species (ROS), endoplasmic reticulum stress and pro-inflammatory cytokines, and it is involved in the pathogenesis of various diseases. AREAS COVERED: In this review, the authors describe recent literature concerning the intricate and elaborate regulation system of ASK1, the function of ASK1 during a cellular stress response and the involvement of ASK1 in many diseases, including cancer, neurodegenerative diseases, infections, diabetes and cardiovascular diseases. EXPERT OPINION: In certain disease conditions, ASK1 plays a protective role, whereas ASK1 can exacerbate the pathology of other diseases. Although ASK1 is involved in various diseases, there is no therapy or drug that targets ASK1 for use in a clinical setting. Recently, ASK1 inhibitors (K811 and MSC2032964A) have emerged, and their therapeutic potentials have been tested in vivo. ASK1 is currently receiving considerable attention as a new therapeutic target.

Entities:  

Keywords:  apoptosis; apoptosis signal-regulating kinase 1; cancer; endoplasmic reticulum stress; infection; neurodegenerative diseases; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24660755     DOI: 10.1517/14728222.2014.896903

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  31 in total

1.  NASH: Novel therapeutic strategies targeting ASK1 in NASH.

Authors:  Susanne Schuster; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-04-05       Impact factor: 46.802

2.  Differential peroxiredoxin hyperoxidation regulates MAP kinase signaling in human articular chondrocytes.

Authors:  John A Collins; Scott T Wood; Jesalyn A Bolduc; N P Dewi Nurmalasari; Susan Chubinskaya; Leslie B Poole; Cristina M Furdui; Kimberly J Nelson; Richard F Loeser
Journal:  Free Radic Biol Med       Date:  2019-01-09       Impact factor: 7.376

3.  Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1.

Authors:  Johannes F Weijman; Abhishek Kumar; Sam A Jamieson; Chontelle M King; Tom T Caradoc-Davies; Elizabeth C Ledgerwood; James M Murphy; Peter D Mace
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-27       Impact factor: 11.205

4.  Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors.

Authors:  Zhili Xin; Martin K Himmelbauer; J Howard Jones; Istvan Enyedy; Rab Gilfillan; Thomas Hesson; Kristopher King; Douglas J Marcotte; Paramasivam Murugan; Joseph C Santoro; Felix Gonzalez-Lopez de Turiso
Journal:  ACS Med Chem Lett       Date:  2020-02-12       Impact factor: 4.345

5.  Biophysical and structural characterization of the thioredoxin-binding domain of protein kinase ASK1 and its interaction with reduced thioredoxin.

Authors:  Dalibor Kosek; Salome Kylarova; Katarina Psenakova; Lenka Rezabkova; Petr Herman; Jaroslav Vecer; Veronika Obsilova; Tomas Obsil
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

Review 6.  Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.

Authors:  Alexander J Kovalic; Sanjaya K Satapathy; Naga Chalasani
Journal:  Hepatol Int       Date:  2018-03-29       Impact factor: 6.047

Review 7.  CIB1: a small protein with big ambitions.

Authors:  Tina M Leisner; Thomas C Freeman; Justin L Black; Leslie V Parise
Journal:  FASEB J       Date:  2016-04-26       Impact factor: 5.191

8.  Oxidized Albumin-A Trojan Horse for p38 MAPK-Mediated Inflammation in Decompensated Cirrhosis.

Authors:  Francesca Cingolani; Mark J Czaja
Journal:  Hepatology       Date:  2018-10-11       Impact factor: 17.425

9.  Glycogen synthase kinase-3β antagonizes ROS-induced hepatocellular carcinoma cell death through suppression of the apoptosis signal-regulating kinase 1.

Authors:  Na Zhang; Lu Liu; Yueying Dou; Danqing Song; Hongbin Deng
Journal:  Med Oncol       Date:  2016-05-24       Impact factor: 3.064

10.  Assembly Dynamics and Stoichiometry of the Apoptosis Signal-regulating Kinase (ASK) Signalosome in Response to Electrophile Stress.

Authors:  Joel D Federspiel; Simona G Codreanu; Amy M Palubinsky; Ama J Winland; Carlos Morales Betanzos; BethAnn McLaughlin; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2016-03-22       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.